To include your compound in the COVID-19 Resource Center, submit it here.

Chemo-proof T cells

Incysus's chemo-resistant γδ T cells could treat solid tumors

T cell therapies have shown unprecedented efficacy in hematologic malignancies, but haven’t produced the same results in solid tumors and have dangerous toxicities. By combining engineered, drug-resistant γδ T cells with chemotherapy, Incysus Ltd. has hit upon a strategy that may be safer and more effective against solid tumors than conventional T cell therapies.

The αβ T cells most T cell therapies use are antigen-specific and may not eliminate the

Read the full 696 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers